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Comparisons among countries can help to identify opportunities for the reduction
of inequalities in cardiometabolic health. The present cross-sectional analysis and
meta-analysis aim to address to what extent obesity traits, socioeconomic, and
behavioral factors determine poor metabolic health across body mass index (BMI)
categories in two urban population-based samples from Central Europe. Data from the
CoLaus (∼6,000 participants; Lausanne, Switzerland) and the Kardiovize Brno 2030
(∼2,000 participants; Brno, Czech Republic) cohorts. For each cohort, logistic regression
analyses were performed to identify the main determinants of poor metabolic health
overall and stratified by body mass index (BMI) categories. The results of each cohort
were then combined in a meta-analysis. We first observed that waist circumference and
body fat mass were associated withmetabolic health, especially in non-obese individuals.
Moreover, increasing age, being male, having low-medium educational level, abdominal
obesity, and high body fat mass were the main determinants of the metabolically
unhealthy profile in both cohorts. Meta-analysis stratified by BMI categories confirmed
the previous results with slight differences across BMI categories. In fact, increasing age
and being male were the main determinants of poor metabolic health independent of
obesity status. In contrast, low educational level and current smoking were associated
with poor metabolic health only in non-obese individuals. In line, public health strategies
against obesity and related comorbidities should aim to improve social conditions and to
promote healthy lifestyles before the progression of metabolic disorders.
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INTRODUCTION
Obesity is a growing plague that imposes devastating health and financial tolls on individuals and
society. Obesity is associated with higher mortality rates driven by comorbidities such as type 2
diabetes mellitus, dyslipidemia, hypertension, and certain types of cancer (1). Conversely, a body
mass index (BMI) in the normal range is associated with a decreased risk of cardio-metabolic
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disease and all-cause mortality. However, not all subjects in a
certain BMI range have a similar risk. Research on metabolically
healthy obesity and metabolically unhealthy obesity (MUO)
suggests that for a certain BMI, the risk of cardio-metabolic
disease and death varies substantially among subjects (2). The
metabolically obese normal weight phenotype, which represents
∼10–25% of the normal weight adult population, has been
described as a unique subgroup of subjects with metabolic
dysregulation similar to obese subjects, despite not being obese
according to BMI criteria. The prevalence of metabolically obese
normal weight individuals is thus somewhat variable among
studies (3). Compared to normal weight and metabolically
healthy subjects, metabolically obese normal weight subjects have
a 3-fold higher risk of all-cause mortality and/or cardiovascular
events (2). Conversely, a large meta-analysis showed that,
compared to normal weight and metabolically healthy subjects,
subjects withmetabolically healthy obesity are not at an increased
risk of all-cause mortality and/or cardiovascular events (4).
Interestingly, in the meta-analysis the highest risk was found
for metabolically obese normal weight (4). To date, it is
unclear if metabolically healthy obesity and metabolically obese
normal weight status are only transient conditions or permanent
phenotypes associated with specific behavioral and/or genetic
determinants. Moreover, the prognostic value of metabolically
healthy obesity is hotly debated, mainly because it likely shifts
gradually toward MUO (3).
In Europe, the rates of cardiovascular disease, obesity and
metabolic disorders are substantially higher in groups of
lower socioeconomic status, and those inequalities between
socio-economic groups tend to increase across a north-south
gradient (5). Large variability and absence of such gradient
are observed in central, eastern and Baltic European countries
(5). Interestingly, the gradient of cardio-metabolic disorders
among socioeconomic groups could be partially mediated by
several behaviors including diet, physical activity, smoking,
and alcohol consumption, which vary enormously among
European countries. Thus, comparisons among countries can
help to identify opportunities for the reduction of inequalities
in health.
To answer these requests, we compared two well-
established population-based studies designed to investigate the
epidemiology and genetic determinants of cardiovascular and
metabolic risk factors: the CoLaus (∼6,000 participants;
Lausanne, Switzerland) (6) and the Kardiovize Brno
2030 (∼2,000 participants; Brno, Czech Republic) (7).
Here, our objectives were: (1) to address to what extent
obesity traits—especially BMI, waist circumference and
body fat mass—determine metabolic health, and (2) to
identify the socioeconomic and behavioral determinants
associated with unhealthy metabolic profile in the overall
population and stratified by BMI categories. To do that,
we used data from urban population based samples in
two Central European countries, Czech Republic and
Switzerland, displaying a similar size population but with
a 4-fold difference in gross domestic product (GDP) per
capita (8).
MATERIALS AND METHODS
Study Populations
The Kardiovize Brno 2030 study is a population-based
prospective cohort study assessing the complex relationships
of biological, psychosocial, environmental, and behavioral risk
factors with cardiovascular diseases (CVD) outcomes, in a
randomly selected ∼1% of the urban population of Brno, Czech
Republic (7, 9–14). The initial recruitment was completed in
2014, and enrolled 2,160 participants (54.8% women) aged 25–64
years. Follow-up has been planned every 5 years until 2030.
The CoLaus study is a population-based study assessing the
clinical, biological, and genetic determinants of cardiovascular
disease in the city of Lausanne, Switzerland. Its aims and
sampling strategy have been reported previously (6). Recruitment
began in June 2003 and ended in May 2006, enrolling 6,733
participants and follow-ups were performed in 2009–2012
and 2014–2017.
Study protocols and baseline examinations were fully
described elsewhere (6, 7). Participation rates were 34% in the
Kardiovize cohort and 41% in the Colaus cohort, respectively.
Ethics Approval and Consent to Participate
The baseline study protocol of the Kardiovize Brno 2030
study was approved by the Ethics Committee of St Anne’s
University Hospital, Brno, Czech Republic (reference 2 G/2012).
The institutional Ethics Committee of the University of
Lausanne, which afterwards became the Ethics Commission of
Canton Vaud (www.cer-vd.ch), approved the baseline CoLaus
study (reference 16/03, decisions of 13th January and 10th
February 2003), and the approval was renewed for each
follow-up. Both studies were performed in agreement with
the Helsinki declaration and its former amendments. All
participants gave their signed informed consent before entering
the study.
Data Collection and Study Design
In both studies, data were collected by trained interviewers
through structured questionnaires. Physical examinations and
blood collections after an overnight fasting were performed
according to standardized and validated protocols (7).
In the current cross-sectional analysis, we used baseline
data from participants with complete assessment of socio-
economic information and clinical parameters, and no
history of CVD.
Socio-Economic Data
Educational level was categorized as low (primary education or
apprenticeship), medium (secondary education), or high (tertiary
education). Marital status was categorized into living in couple
(married and other relationship) or living alone (single, divorced
or widowed). Employment status was categorized into employed
(full-time or part-time employment) or unemployed (including
retired due to the low prevalence of unemployed). Smoking status
was self-reported and defined as current, former or never.
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Clinical Data
In both studies, clinical data, as well as body weight, height
and waist circumference (WC) were measured using standard
procedures described elsewhere (6, 7). BMI—calculated as weight
in kilograms divided by height in meters squared—was used to
classify patients as normal weight (BMI < 25 kg/m2), overweight
(25 ≤ BMI < 30 kg/m2), or obese (BMI ≥ 30 kg/m2). Due
to the low prevalence of underweight participants (BMI < 18.5
kg/m2; 2.2% in Kardiovize cohort, 1.6% in CoLaus cohort),
especially of metabolically unhealthy underweight participants in
this subgroup, we included only those with BMI ≥ 18.5 kg/m2.
Abdominal obesity was defined asWC≥ 102 cm in men andWC
≥ 88 cm in women.
In the Kardiovize study, blood pressure was measured using
a mercury sphygmomanometer (Baumanometer, W.A. Baum,
Co., Inc., USA). Body fat mass (BFM) was assessed using
a direct segmental multi-frequency bioelectrical impedance
analysis (InBody 370; BIOSPACE Co., Ltd., Seoul, Korea).
Biochemical analyses were performed on fasting blood samples
using a Modular SWA P800 analyzer (Roche, Basel, Switzerland).
Total cholesterol, triglycerides and glucose were measured
by the enzymatic colorimetric method (Roche Diagnostics
GmbH, Germany). HDL-cholesterol was measured using the
homogeneousmethod for direct measuring without precipitation
(Sekisui Medical, Japan). For triglycerides <4.5 mmol/l, the
LDL-cholesterol level was calculated according to the Friedewald
equation. For triglycerides>4.5 mmol/l, the LDL-cholesterol was
calculated using the homogeneous method for direct measuring
(Sekisui Medical, Japan).
In the Colaus study, blood pressure was measured
using an Omron R© HEM-907 automated oscillometric
sphygmomanometer after at least a 10-min rest in a seated
position, and the average of the last two measurements was
used. BFM was assessed by electrical bioimpedance using the
Bodystat R© 1500 body mass analyzer (Bodystat Ltd, Isle of Man,
England). In a subset of 794 women who also had their body
composition assessed using DEXA, the correlation for BFM
estimated by bioimpedance and DEXA was 0.852 (p < 0.001),
with only a slight overestimation by bioimpedance relative
to DEXA (+0.9 kg). Biological analyses were performed on a
Modular P apparatus (Roche Diagnostics, Basel, Switzerland).
The following analytical procedures (with maximum inter
and intra-batch CVs) were used: total cholesterol by CHOD-
PAP (1.6–1.7%); HDL-cholesterol by CHOD-PAP + PEG +
cyclodextrin (3.6–0.9%); triglycerides by GPO-PAP (2.9–1.5%);
glucose by glucose dehydrogenase (2.1–1.0%).
Definition of Metabolic Health
According to the International Diabetes Federation (15), we
defined metabolic unhealthy individuals those who presented
at least one of the following criteria: (i) systolic/diastolic blood
pressure ≥130/85mm Hg or use of antihypertensive drug; (ii)
triglycerides level ≥150 mg/dl; (iii) HDL-cholesterol level <40
mg/dl in men or <50 mg/dl in women or use of lipid-lowering
drugs; (iv) glucose level ≥100 mg/dl or use of antidiabetic drug.
This partially differed from the definition of metabolic syndrome
because it did not depend on abdominal obesity. Based on this
definition, participants were classified as metabolically healthy or
metabolically unhealthy in the whole cohorts and within normal
weight, overweight, and obese subgroups.
Inclusion and Exclusion Criteria
In this cross-sectional analysis, we used data fromKardiovize and
CoLaus members with complete assessment of anthropometric
and metabolic parameters, and no history of CVD.
Statistical Analysis
Statistical analyses were performed separately for the Kardiovize
and Colaus cohorts using the SPSS software (version 25.0, SPSS,
Chicago, IL). The Kolmogorov-Smirnov test was used to test
the normality of continuous variables prior to further analyses.
Descriptive results are expressed as number of participants
(percentage) for categorical variables, or as median (interquartile
range, IQR) for continuous variables with skewed distribution.
Bivariate analyses were performed using Chi-square test for
bivariate or categorical variable, and Mann-Whitney U-test
or Kruskal–Wallis test for continuous variables. We first
evaluated whether anthropometric measures were associated
with metabolically unhealthy profile in the whole cohorts and
stratified by BMI categories. To do that, we applied different
logistic regression models including BMI, waist circumference
or body fat mass as independent variable and adjusting for
social and behavioral factors that were significantly associated
with the unhealthy metabolic profile in at least one cohort
(i.e., age, gender, educational level, marital status, employment
status, and smoking status). Next, we investigated the main social
and behavioral factors associated with metabolically unhealthy
profile in the whole cohorts and stratified by BMI categories.
In this case, we used logistic regression models including social
and behavioral factors that were significantly associated with
the unhealthy metabolic profile in at least one cohort (i.e., age,
gender, educational level, marital status, employment status, and
smoking status). We also tested for interaction between BMI and
social or behavioral factors to understand if the estimates for
the same exposure differed across BMI categories. Results were
expressed as Odds ratio (OR) and 95% confidence interval (CI).
All statistical tests were two-sided, and p < 0.05 were considered
statistically significant.
Meta-Analysis
For each association between behavioral or social factors and
metabolic health, we meta-analyzed the adjusted ORs obtained
from each cohort using the Review Manager software (Version
5.3.1). The obtained pooled ORs were reported for the overall
population or stratified by BMI categories. For each meta-
analysis, heterogeneity across studies was measured using the
Q-test and p < 0.1 was considered statistically significant (16).
According to heterogeneity across studies, we used the fixed-
effects model (Mantel–Haenszel method) when heterogeneity
was negligible or the random-effects models (DerSimonian-Laird
method) when heterogeneity was significant. The significance of
pooled ORs was determined by the Z-test. Except for the Q-
test, p < 0.05 was considered statistically significant, and all tests
were 2-sided.
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FIGURE 1 | Fluxogram of participants’ inclusion in the current analysis. The fluxogram displays the flow of participants and reasons for exclusion in the current
analysis for the Kardiovize (A) and Colaus (B) cohorts.
RESULTS
Selection and Characteristics of Included
Participants
Figure 1 displays the flowchart of participants’ inclusion in
the current analysis. From the initial 2,160 participants of the
Kardiovize cohort, 308 were excluded because of missing or
outlier data (n = 185), BMI < 18.5 kg/m2 (n = 48) or history of
CVD (n = 75). From the initial 6,733 participants of the Colaus
cohort, 988 were excluded because of missing or outlier data (n
= 473), BMI < 18.5 kg/m2 (n = 108) or history of CVD (n
= 407). The characteristics of included participants according
to BMI categories are summarized in Table 1. In both cohorts,
overweight and obese participants were older, more frequently
men, less educated, and less frequently employed or living alone
than their normal weight counterparts. The proportion of never
smokers decreased with increasing BMI among the Kardiovize
participants, while it increased in the Colaus cohort. Similarly,
the proportion of current smokers increased with increasing BMI
in the Kardiovize while it decreased in the CoLaus cohort.
In both cohorts, all anthropometric and clinical parameters
increased from normal weight to obese participants, except of
HDL-cholesterol, which decreased. As expected, the prevalence
of abdominal obesity, diagnosed and treated hypertension, type 2
diabetes and hypercholesterolemia, were higher in the overweight
and obese subgroups. The proportion of metabolically unhealthy
participants increased across BMI categories, ranging from 10.1
to 58.7% in the Kardiovize cohort, and from 21.5 to 71.5% in the
Colaus cohort.
Anthropometric Measures and Metabolic
Health
The characteristics of participants according to their metabolic
status are reported in the Supplementary Material. In both
cohorts, metabolically unhealthy participants were older, more
frequently men and smokers, and less educated and employed
than their metabolically healthy counterparts. In the Colaus
cohort, metabolically unhealthy participants were also less
likely to live alone. In both cohorts, metabolically unhealthy
participants exhibited higher BMI, waist circumference and body
fat mass, which resulted in a higher prevalence of abdominal
obesity compared with those who were metabolically healthy.
Compared with the latter, metabolically unhealthy participants
also exhibited higher levels for most clinical parameters, except
for beneficial HDL-cholesterol levels, which were lower. The
prevalence of diagnosed or treated hypertension, diabetes, and
hypercholesterolemia was higher in metabolically unhealthy
participants than in metabolically healthy participants.
Notably, logistic regression analysis showed that BMI, waist
circumference and body fat mass were positively associated with
metabolically unhealthy profile in both cohorts, after adjusting
for age, gender, educational level, marital status, employment
status, and smoking status (Table 2). Moreover, stratified analysis
confirmed the association of waist circumference and body fat
mass withmetabolic status among normal weight and overweight
individuals. By contrast, no association of waist circumference or
body fat mass with metabolically unhealthy profile was evident
among obese participants (Table 2).
Social and Behavioral Determinants of
Metabolic Health Across BMI Categories
We next evaluated social and behavioral factors associated with
metabolic health in the overall population. Notably, logistic
regression analysis demonstrated that increasing age, being
male, and having low-medium educational level were the main
determinants of the metabolically unhealthy profile in both
cohorts. Further, we observed significant associations with
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TABLE 1 | Characteristics of participants according to BMI categories.
Characteristicsa Kardiovize (n = 1,852) Colaus (n = 5,745)
Normal Overweight Obese P-value Normal Overweight Obese P-value
Sample size 887 631 334 2,756 2,126 863
Men 35.7% (317) 59.3% (374) 46.1% (154) <0.001 37.7% (1,038) 58.4% (1,241) 50.1% (432) <0.001
Age, years 43.0 (18.0) 49.0 (18.0) 53.5 (14.0) <0.001 49.1 (17.0) 53.3 (17.0) 55.2 (16.0) <0.001
Marital status 0.002 <0.001
Living alone 41.8% (371) 33.0% (208) 36.9% (123) 43.7% (1,205) 38.6% (822) 36.8% (318)
Living in couple 58.2% (516) 67.0% (423) 63.1% (211) 56.3% (1,551) 61.4% (1,304) 63.2% (545)
Educational level <0.001 <0.001
High 48.6% (431) 39.9% (252) 29.0% (97) 24.3% (670) 16.7% (355) 9.2% (79)
Medium 37.1% (329) 38.5% (243) 41.6% (139) 26.9% (740) 22.6% (480) 18.5% (160)
Low 14.4% (127) 21.6% (136) 29.3% (98) 48.8% (1,346) 60.7% (1,291) 72.4% (625)
Employment status <0.001 <0.001
Unemployed 15.1% (134) 16.3% (99) 25.2% (104) 25.6% (706) 31.9% (678) 42.3% (365)
Employed 84.9% (753) 83.7% (509) 74.8% (250) 74.4% (2,050) 68.1% (1,448) 57.7% (498)
Smoking status 0.006 <0.001
Never 55.1% (489) 47.1% (297) 48.5% (162) 40.7% (1,122) 40.0% (849) 44.5% (384)
Former 18.3% (162) 25.4% (160) 23.4% (78) 29.0% (798) 34.9% (741) 34.9% (301)
Current 26.6% (236) 27.5% (174) 28.1% (94) 30.3% (836) 25.1% (534) 20.6% (178)
Abdominal obesity 2.6% (23) 42.3% (266) 97.0% (324) <0.001 4.2% (116) 37.2% (790) 91.8% (792) <0.001
BMI, kg/m2 22. 5 (2.8) 27.1 (2.4) 33. 8 (4.3) <0.001 22.6 (2.7) 27.1 (2.3) 32.5 (3.9) <0.001
Waist circumference, cm 79.0 (11.0) 94.0 (11.0) 107.0 (14.0) <0.001 80.0 (12.0) 94.0 (11.0) 106.0 (13.0) <0.001
Body fat mass, % 21.6 (10.2) 26.6 (12.6) 38.2 (13.4) <0.001 26.0 (12.0) 28.0 (13.7) 37.8 (15.0) <0.001
SBP, mm Hg 113.0 (17.0) 120.5 (18.5) 127.0 (19.0) <0.001 121.0 (20.5) 129.8 (21.5) 134.5 (24.0) <0.001
DBP, mm Hg 76.5 (12.0) 81.5 (12.5) 84.0 (11.0) <0.001 76.0 (13.0) 80.5 (13.5) 84.0 (13.0) <0.001
Glucose, mmol/L 4.7 (0.70) 5.0 (0.7) 5.2 (0.8) <0.001 5.2 (0.6) 5.5 (0.8) 5.7 (1.1) <0.001
Total cholesterol, mmol/L 5.0 (1.3) 5.3 (1.3) 5.2 (1.4) <0.001 5.4 (1.3) 5.7 (1.4) 5.6 (1.4) <0.001
Triglycerides, mmol/L 0.8 (0.5) 1.3 (0.9) 1.4 (0.8) <0.001 0.9 (0.6) 1.3 (0.9) 1.5 (1.1) <0.001
HDL cholesterol, mmol/L 1.6 (0.5) 1.4 (0.5) 1.3 (0.4) <0.001 1.8 (0.6) 1.5 (0.5) 1.4 (0.5) <0.001
LDL cholesterol, mmol/L 2.89 (1.15) 3.25 (1.18) 3.23 (1.18) <0.001 3.1 (1.1) 3.5 (1.2) 3.4 (1.1) <0.001
Metabolic health <0.001 <0.001
Healthy 89.9% (797) 63.5% (401) 41.3% (138) 78.5% (2,163) 49.1% (1,044) 28.5% (246)
Unhealthy 10.1% (90) 36.5% (230) 58.7% (196) 21.5% (593) 50.9% (1,082) 71.5% (617)
Diagnosis of type 1 diabetes 1.0% (9) 0.5% (3) 0.0% (0) 0.115 0.2% (5) 0.2% (4) 0.2% (2) 0.956
Diagnosis of type 2 diabetes 0.8% (7) 3.5% (22) 8.7% (29) <0.001 1.2% (34) 3.4% (73) 12.9% (111) <0.001
Oral antidiabetic treatment 0.2% (2) 3.5% (22) 7.2% (24) <0.001 0.8% (21) 2.5% (53) 10.2% (88) <0.001
Insulin treatment 1.1% (10) 0.5% (3) 0.9% (3) 0.399 0.4% (11) 0.4% (8) 1.6% (14) <0.001
Diagnosis of hypertension 16.6% (146) 33.7% (210) 62.8% (209) <0.001 14.3% (393) 29.8% (634) 49.0% (423) <0.001
Antihypertensive drug treatment 9.2% (82) 21.6% (136) 49.1% (164) <0.001 7.8% (215) 19.3% (411) 36.7% (317) <0.001
Diagnosis of high cholesterol 20.4% (176) 36.4% (220) 38.0% (124) <0.001 14.9% (412) 26.8% (569) 33.7% (291) <0.001
Hypolipidemic drug treatment 2.8% (25) 9.4% (59) 14.4% (48) <0.001 6.1% (170) 12.6% (268) 18.0% (156) <0.001
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein. aResults are reported as median
(interquartile range) or percentage. Statistical analysis using Chi-square test for bivariate or categorical variable, and Kruskal–Wallis test for continuous variables.
unemployed status in the Kardiovize cohort, and with current
smoking in the Colaus cohort (Table 3).
We also observed a significant interaction between
educational level and BMI categories on the relationship with
metabolic health (p = 0.008). Although no interactions between
BMI and other social and behavioral factors were evident (p
> 0.05), we performed stratified analysis by BMI categories
(bivariate analyses are showed in Supplementary Material).
Logistic regression analysis among normal weight individuals
demonstrated that increasing age, being male, and having a
low-medium educational level were the main determinants of
a metabolically unhealthy profile in both cohorts, while current
smokingmaintained a significant associationwith ametabolically
unhealthy profile in the CoLaus cohort (Table 3). Among
overweight individuals, increasing age, being male, and current
smoking were the main social and behavioral determinants of
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TABLE 2 | Association of anthropometric measures with metabolically unhealthy status.
Characteristics Kardiovize CoLaus
OR 95% CI p-value OR 95% CI p-value
Overall
BMI, kg/m2a 1.17 (1.14–1.20) <0.001 1.17 (1.14–1.20) <0.001
Waist circumference, cma 1.08 (1.06–1.11) <0.001 1.08 (1.06–1.09) <0.001
Body fat mass, %a 1.08 (1.06–1.10) <0.001 1.08 (1.06–1.09) <0.001
Normal weight
Waist circumference, cma 1.08 (1.04–1.14) 0.001 1.05 (1.03–1.08) <0.001
Body fat mass, %a 1.09 (1.04–1.14) 0.001 1.05 (1.03–1.08) <0.001
Overweight
Waist circumference, cma 1.05 (1.01–1.09) 0.027 1.03 (1.01–1.06) 0.004
Body fat mass, %a 1.05 (1.01–1.09) 0.024 1.02 (1.01–1.04) 0.004
Obese
Waist circumference, cma 1.03 (0.98–1.07) 0.217 1.02 (0.98–1.05) 0.354
Body fat mass, %a 1.03 (0.99–1.08) 0.194 1.02 (0.98–1.05) 0.342
aPer one unit increase; BMI, body mass index. Results are expressed as multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI). Statistical analysis was performed using
logistic regression models including BMI, waist circumference or body fat mass as independent variable and adjusting for age, gender, educational level, marital status, employment
status, and smoking status.
the metabolically unhealthy profile in both cohorts (Table 3).
Among obese subjects, increasing age and being male were
the main determinants of a metabolically unhealthy profile in
both cohorts, while having a medium educational level was
significantly associated with unhealthy metabolic status only in
the Kardiovize cohort (Table 3).
Meta-Analysis of the Associations of
Social and Behavioral Factors With
Metabolic Health
To understand to what extent social and behavioral factors
contributed to metabolic health, we meta-analyzed adjusted
ORs obtained from logistic regression analyses on each cohort.
The pooled adjusted ORs of the associations between social
and behavioral factors and a metabolic unhealthy profile were
calculated in the overall population and also stratified by BMI
categories (Figure 2).
In the overall population, the main determinants of the
metabolically unhealthy profile were increasing age, being male,
low educational level, and current smoking (Figure 2A).
Among normal weight participants, the main determinants
of the metabolically unhealthy profile were increasing age,
being male, low-medium educational level, and current
smoking (Figure 2B).
Among overweight participants, the main determinants of the
metabolically unhealthy profile were increasing age, being male,
and current smoking (Figure 2C).
Among obese participants, the main determinants of the
metabolically unhealthy profile were only increasing age and
being male (Figure 2D).
DISCUSSION
BMI is widely accepted as an obesity marker in population-
based studies because, in the general population, metabolic health
often declines as BMI increases. However, some obese individuals
maintain metabolic health (2, 3). It is also increasingly clear
that BMI is a rather poor indicator of body fat distribution
and percentage at the individual level. For this reason, waist
circumference and body fat mass remain among the most
investigated obesity indicators in the research on metabolic
health. In this scenario, our study evaluated the association
between the above mentioned anthropometric measures and
metabolic health in two urban population-based samples from
Central Europe. In general, we confirmed that obesity traits were
the main factors associated with poor metabolic health, but we
also revealed some peculiar differences across BMI categories.
In fact, waist circumference and body fat mass seemed to be
associated with poor metabolic health among normal weight
and overweight individuals from both cohorts. Conversely, the
same indicators were not associated with the metabolic status
among obese individuals. If it was true that participants could
be considered metabolically unhealthy for reasons not related
to obesity (type 1 diabetes, familiar dyslipidemia, essential
hypertension etc.), the effects of other risk factors for poor
metabolic health might partially explain this difference (9, 13).
Therefore, we aimed to provide the first comparison of
determinants of metabolic health across BMI categories between
two urban populations from Central-Eastern and Central-
Western Europe. Interestingly, we demonstrated that increasing
age, male gender, and low-medium educational level were the
main social determinants of the metabolically unhealthy profile
in both cohorts. Although educational level varies extremely
between Czech and Swiss (17), it is considered the most
important sociodemographic variable behind healthy choice,
especially in terms of dietary habits (18). In fact, education
might confer more knowledge about benefits and risks of
dietary choices (19), and might also shape beliefs, attitudes,
and behavior (20). In line, our study demonstrated that low
educational level was associate with metabolically unhealthy
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TABLE 3 | Multivariable associations of social and behavioral factors with metabolically unhealthy status.
Characteristics Kardiovize CoLaus
OR 95% CI p-value OR 95% CI p-value
Overall
Agea 1.03 (1.04–1.06) <0.001 1.04 (1.03–1.05) <0.001
Man vs. woman 6.55 (4.61–9.31) <0.001 8.51 (7.03–10.30) <0.001
Educational level 0.003b 0.001b
High 1 (ref.) 1 (ref.)
Medium 1.61 (1.21–2.13) 0.001 1.14 (0.94–1.38) 0.192
Low 1.12 (0.79–1.57) 0.534 1.43 (1.21–1.70) <0.001
Living alone vs. living in couple 1.06 (0.82–1.37) 0.670 1.02 (0.90–1.16) 0.756
Unemployed vs. employed 1.47 (1.04–2.06) 0.028 0.99 (0.85–1.17) 0.940
Smoking status 0.122b 0.002b
Never 1 (ref.) 1 (ref.)
Former 0.93 (0.68–1.27) 0.641 1.10 (0.96–1.28) 0.181
Current 1.28 (0.96–1.71) 0.090 1.32 (1.13–1.54) <0.001
Normal weight
Agea 1.07 (1.04–1.10) <0.001 1.06 (1.04–1.07) <0.001
Man vs. woman 4.57 (2.26–9.26) <0.001 6.31 (4.60–8.65) <0.001
Educational level 0.013b <0.001b
High 1 (ref.) 1 (ref.)
Medium 2.31 (1.32–4.05) 0.003 1.22 (0.90–1.66) 0.194
Low 1.90 (0.95–3.82) 0.072 1.75 (1.34–2.28) <0.001
Living alone vs. living in couple 1.36 (0.83–2.23) 0.230 1.03 (0.84–1.26) 0.811
Unemployed vs. employed 1.12 (0.58–2.17) 0.738 1.01 (0.77–1.31) 0.968
Smoking status 0.854b 0.008b
Never 1 (ref.) 1 (ref.)
Former 0.90 (0.45–1.78) 0.818 1.06 (0.83–1.34) 0.630
Current 1.12 (0.64–1.98) 0.736 1.44 (1.13–1.83) 0.003
Overweight
Agea 1.04 (1.02–1.06) <0.001 1.04 (1.03–1.05) <0.001
Man vs. woman 5.26 (2.80–9.90) <0.001 4.24 (3.02 - 5.94) <0.001
Educational level 0.518b 0.875b
High 1 (ref.) 1 (ref.)
Medium 1.27 (0.83–1.92) 0.269 1.05 (0.78–1.42) 0.753
Low 1.21 (0.74–1.99) 0.448 1.05 (0.87–−1.35) 0.682
Living alone vs. living in couple 1.01 (0.69–1.50) 0.948 0.98 (0.80–1.15) 0.889
Unemployed vs. employed 1.53 (0.89–2.61) 0.121 0.88 (0.70–1.12) 0.294
Smoking status 0.005b 0.035b
Never 1 (ref.) 1 (ref.)
Former 0.76 (0.48–1.20) 0.239 1.16 (0.94–1.43) 0.178
Current 1.69 (1.11–2.57) 0.015 1.36 (1.08–1.72) 0.010
Obesity
Agea 1.03 (1.01–1.06) 0.024 1.06 (1.04–1.08) <0.001
Man vs. woman 3.30 (1.57–6.93) 0.002 3.12 (1.81–5.40) <0.001
Educational level 0.022b 0.400b
High 1 (ref.) 1 (ref.)
Medium 1.87 (1.03–3.37) 0.039 0.83 (0.45–1.52) 0.545
Low 0.86 (0.45–1.65) 0.651 1.09 (0.62–1.91) 0.763
Living alone vs. living in couple 1.03 (0.62–1.70) 0.910 1.31 (0.94–1.83) 0.117
Unemployed vs. employed 1.80 (0.94–3.43) 0.076 1.25 (0.86–1.81) 0.248
Smoking status 0.693b 0.392b
Never 1 (ref.) 1 (ref.)
Former 1.22 (0.65–2.28) 0.543 1.10 (0.76–1.59) 0.620
Current 0.91 (0.51–1.62) 0.739 1.35 (0.88–2.08) 0.171
aPer one unit increase; bp-value for trend. BMI, body mass index. Results are expressed as multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI). Statistical analysis
was performed using logistic regression models including all the variables in the table (i.e., age, gender, educational level, marital status, employment status, and smoking status).
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FIGURE 2 | Pooled adjusted ORs for the association of behavioral and social factors with poor metabolic health, obtained from meta-analyses. These plots shows the
pooled ORs in he overall population (A; n = 7,597), or stratified in normal weight (B; n = 3,643), overweight (C; n = 2,757), or obese (D; n = 1,197) subgroups.
Pooled adjusted ORs were estimated through meta-analyses of adjusted ORs obtained from logistic regression analyses on each cohort. Meta-analyses were based
on the fixeda or the randomb effects model. Relative weightc is related to adjusted ORs from the Kardiovize cohort, obtained through the fixed or the random effect
model, and expressed as percentage. Metabolic health was defined according to the International Diabetes Federation (15).
Frontiers in Public Health | www.frontiersin.org 8 April 2020 | Volume 8 | Article 108
Kunzova et al. Determinants of Metabolic Health
profile among normal weight individuals from the Colaus cohort.
Medium educational level, instead, was associated with unhealthy
metabolic status among normal weight and obese individuals
from the Kardiovize cohort.
With respect to behaviors, current smoking was one of
the main determinants of metabolic health in normal weight
individuals from the Colaus cohort and in overweight individuals
from both cohort. Prevalence of current smokers and price of
cigarettes are similar in Czech Republic and in Switzerland (21);
however, when considering the GDP-PPP adjusted price of a pack
of cigarettes and annual per adult cigarette consumption, Swiss
consume almost the double the number of cigarettes than Czech
people (21), both of domestic of foreign brands, whichmight help
to explain the observed causative differences in epidemiological
associations. Several observational studies demonstrated that
current smoking was associated with abdominal obesity, but not
with overall obesity, as in metabolically obese normal weight
individuals (22, 23). For instance, a study enrolling 21,828
participants aged 45–79 fromNorfolk (UK) found that, even after
multivariable adjustment, abdominal obesity was highest among
current smokers and lowest among never smokers (24). It has
been suggested that smoking has some anti-estrogenic effect or
may have an effect on the uptake and storage of triglyceride fatty
acids, increasing fat mass (25).
To address to what extent clinical, social and behavioral
determinants affected metabolic health, we finally meta-analyzed
results obtained from the two cohorts. In general, a meta-
analysis provides a summary of integrated results analyzed for
their difference. The rationale behind our meta-analysis was to
evaluate the associations of social and behavioral determinants
with metabolic health among different subgroups of participants;
to overcome limitations of small sample size, especially for some
exposures; to feed new hypotheses and to inspire future studies
with larger sample size.
In our study, increasing age and being male were certainly
the main determinants of poor metabolic health, especially in
the presence of obesity. In contrast, smoking status and low
educational level were associated with poor metabolic health
only in non-obese individuals. Overall, these results denoted that
metabolic health in non-obese patients might be also associated
with social and behavioral determinants, while metabolically
unhealthy obesity appeared to be mostly attributed to aging
and male gender. Moreover, it has not yet been fully elucidated
whethermetabolically unhealthy obese individuals are genetically
or epigenetically predisposed (11), or whether metabolically
healthy obesity represents a transitory state to metabolically
unhealthy conditions (26).
Our study has several strengths. Firstly, it was based in
large samples randomly selected from the urban population of
Brno (Czech Republic) and Lausanne (Switzerland). Secondly,
cardio-metabolic parameters and anthropometric measures were
assessed using standard and validated protocols. Thirdly, the
availability of two similar datasets allowed us to exploit the same
statistical approach, instead of relying on previously published
data. Yet, the comparison of two datasets of information that
have been collected by different but comparablemethods requires
caution. In our study, however, we used the same inclusion
criteria for both cohorts, and we analyzed the variables that were
collected by comparable methods (e.g., structured questionnaires
for sociodemographic and behavioral data, and standardized and
validated protocols for clinical data). Finally, the majority of the
results are robust, as they have been confirmed after adjusting
for several socio-demographic and behavioral factors and were
found for both cohorts using logistic regression analysis.
Our study also has some limitations. Firstly, its cross-sectional
design precludes assessing causality. Taking into account the
number of years of exposure to obesity will be of utmost
importance in future longitudinal studies about metabolic
health in human obesity. Secondly, the effect of unmeasured
socio-demographic factors (e.g., income, food security, food
access), behaviors (i.e., dietary habits, sleep deprivation, physical
activity), physiological condition (e.g., menopause status) and
comorbidities cannot be completely excluded. Moreover, the
inclusion of retired people in the unemployed groups may
introduce potential bias, which should be considered when
interpreting our findings. Finally, it was not possible to have a
more detailed assessment of adiposity such as visceral fat area,
active body mass-muscle mass, and epicardial fat between Czech
and Swiss populations.
In conclusion, our findings suggested that body fat mass
and its distribution—expressed in terms percentage and waist
circumference—were associated with metabolic health only
among non-obese individuals. Our study, to the best of our
knowledge, is also the first providing a comparison of social
and behavioral determinants of metabolic health in two Central
European cohorts. Interestingly, it seemed reasonable that age
and gender affected metabolic profile in each BMI category,
while modifiable factors—such as educational level and smoking
habits—appeared crucial only in non-obese individuals. In line,
public health strategies against obesity and related comorbidities
should aim to improve social conditions and to promote healthy
lifestyles before the progression of metabolic disorders.
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